Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
If the medication really isnt making a difference to your hunger, they can recommend other weight loss treatments that may be more suitable, like Mounjaro (tirzepatide)
Individuals at greater risk of low blood sugar whilst taking retatrutide include: Those concurrently prescribed sulphonylureas (e.g., gliclazide, glibenclamide), which stimulate insulin release independently of blood glucose levels dose reduction is often required when initiating potent incretin-based therapies [16] [8] Patients using insulin therapy , where doses may need to be reduced as glycaemic control improves or caloric intake falls People with renal impairment , who may have a generally increased risk of hypoglycaemia, particularly if also taking insulin or sulphonylureas (note: the specific effect of renal impairment on retatrutide clearance has not yet been established, as no SmPC exists) Individuals who are fasting , following a very low-calorie diet, or who have significantly reduced their food intake a common occurrence given retatrutide's appetite-suppressing effects Those with a history of hypoglycaemia or hypoglycaemia unawareness Older adults, who may have reduced counter-regulatory responses to falling blood glucose The appetite suppression associated with retatrutide can lead to substantially reduced caloric intake, which whilst beneficial for weight loss may necessitate a review and reduction of concomitant glucose-lowering therapies
Some metabolic supplements, often dubbed faux-zempic, are marketed to mimic GLP-1 medications, though their mechanisms and effectiveness differ, says Dr
The treatment is not painful at all, and I do feel that even twice has strengthend my core
This rebound reflects the medication's temporary effect on appetite rather than any permanent metabolic change, which is why continuous treatment is now the evidence-based standard for long-term weight management
